Comparative Pharmacology
Head-to-head clinical analysis: DISPERMOX versus PROBAMPACIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISPERMOX versus PROBAMPACIN.
DISPERMOX vs PROBAMPACIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidase activity and disrupting peptidoglycan cross-linking.
PROBAMPACIN is a synthetic aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, causing misreading of mRNA and preventing translocation of peptidyl-tRNA from the A-site to the P-site.
Adults: 1 g (as amoxicillin 875 mg + clavulanate 125 mg) orally every 12 hours for 7-10 days.
100 mg IV every 12 hours over 30 minutes.
None Documented
None Documented
Terminal elimination half-life 1.5 hours; prolonged in renal impairment.
4.5 hours (prolonged to 12-18 hours in severe renal impairment)
Renal excretion 80% as unchanged drug, biliary/fecal 10%.
Renal: 70% unchanged; biliary/fecal: 20% as metabolites; 10% other
Category C
Category C
Penicillin Antibiotic
Penicillin Antibiotic